Sale
Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines
Elsevier Science Publishing Co Inc
$90.53
$80.50
(No reviews yet)
Write a Review
Elsevier Science Publishing Co Inc
Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines
- | By (Author): Tom Brody (Consultant for Second Genome, Inc. (Crohn's disease), Rigel Pharmaceuticals (platelet disorder), PrimeGen Biotech (stem cell therapy), Regeneron Pharmaceuticals (broadly neutralizing antibodies for HIV), and Biogen IDEC (multiple sclerosis)) (Author)
- | Publisher: Elsevier Science Publishing Co Inc
- | Publication Date: Mar 14, 2016
- | Country of Publication: United States
- | Number of Pages: 896 pages
- | Language: NULL
- | Binding: Hardback
- | ISBN-10: 0128042176
- | ISBN-13: 9780128042175
- By (Author):
- Tom Brody (Consultant for Second Genome, Inc. (Crohn's disease), Rigel Pharmaceuticals (platelet disorder), PrimeGen Biotech (stem cell therapy), Regeneron Pharmaceuticals (broadly neutralizing antibodies for HIV), and Biogen IDEC (multiple sclerosis
- Publisher:
- Elsevier Science Publishing Co Inc
- Publication Date:
- Mar 14, 2016
- Country of Publication:
- United States
- Language:
- NULL
- Number of pages:
- 896 pages
- Binding:
- Hardback
- ISBN-10:
- 0128042176
- ISBN-13:
- 9780128042175